Literature DB >> 22535187

Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder.

Aurélie Labbe1, Alexandre Bureau, Isabel Moreau, Marc-André Roy, Yvon Chagnon, Michel Maziade, Chantal Merette.   

Abstract

This study introduces a novel way to use the lifetime ratings of symptoms of psychosis, mania and depression in genetic linkage analysis of schizophrenia (SZ) and bipolar disorder (BP). It suggests using a latent class model developed for family data to define more homogeneous symptom subtypes that are influenced by a smaller number of genes that will thus be more easily detectable. In a two-step approach, we proposed: (i) to form homogeneous clusters of subjects based on the symptom dimensions and (ii) to use the information from these homogeneous clusters in linkage analysis. This framework was applied to a unique SZ and BP sample composed of 1278 subjects from 48 large kindreds from the Eastern Quebec population. The results suggest that our strategy has the power to increase linkage signals previously obtained using the diagnosis as phenotype and allows for a better characterization of the linkage signals. This is the case for a linkage signal, which we formerly obtained in chromosome 13q and enhanced using the dimension mania. The analysis also suggests that the methods may detect new linkage signals not previously uncovered by using diagnosis alone, as in chromosomes 2q (delusion), 15q (bizarre behavior), 7p (anhedonia) and 9q (delusion). In the case of the 15q and 2q region, the results coincide with linkage signals detected in other studies. Our results support the view that dissecting phenotypic heterogeneity by modeling symptom dimensions may provide new insights into the genetics of SZ and BP.

Entities:  

Mesh:

Year:  2012        PMID: 22535187      PMCID: PMC3476706          DOI: 10.1038/ejhg.2012.67

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

1.  Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q.

Authors:  T Paunio; J Ekelund; T Varilo; A Parker; I Hovatta; J A Turunen; K Rinard; A Foti; J D Terwilliger; H Juvonen; J Suvisaari; R Arajärvi; J Suokas; T Partonen; J Lönnqvist; J Meyer; L Peltonen
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

2.  Linkage results on 11Q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia.

Authors:  M Maziade; V Raymond; D Cliche; J P Fournier; C Caron; Y Garneau; L Nicole; P Marcotte; C Couture; C Simard
Journal:  Am J Med Genet       Date:  1995-12-18

3.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.

Authors:  E Lander; L Kruglyak
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

4.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

Authors:  N C Andreasen; M Flaum; S Arndt
Journal:  Arch Gen Psychiatry       Date:  1992-08

5.  A syndrome of severe mental retardation, spasticity, and tapetoretinal degeneration linked to chromosome 15q24.

Authors:  S J Mitchell; D P McHale; D A Campbell; N J Lench; R F Mueller; S E Bundey; A F Markham
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

6.  Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families.

Authors:  M Maziade; M-A Roy; Y C Chagnon; D Cliche; J-P Fournier; N Montgrain; C Dion; J-C Lavallée; Y Garneau; N Gingras; L Nicole; A Pirès; A-M Ponton; A Potvin; H Wallot; C Mérette
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

7.  Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure.

Authors:  M A Roy; G Lanctôt; C Mérette; D Cliche; J P Fournier; P Boutin; C Rodrigue; L Charron; M Turgeon; M Hamel; N Montgrain; L Nicole; A Pirès; H Wallot; A M Ponton; Y Garneau; C Dion; J C Lavallée; A Potvin; P Szatmari; M Maziade
Journal:  Am J Psychiatry       Date:  1997-12       Impact factor: 18.112

8.  Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses.

Authors:  M Maziade; M A Roy; M Martinez; D Cliche; J P Fournier; Y Garneau; L Nicole; N Montgrain; C Dion; A M Ponton
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

9.  Genome-wide association study identifies five new schizophrenia loci.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

10.  Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q.

Authors:  Peter Holmans; George S Zubenko; Raymond R Crowe; J Raymond DePaulo; William A Scheftner; Myrna M Weissman; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; James A Knowles; Madeleine Gladis; Jo Thomas; Jennifer Chellis; Erin Miller; Douglas F Levinson
Journal:  Am J Hum Genet       Date:  2004-04-22       Impact factor: 11.025

View more
  4 in total

1.  Genetic variation in the 3'-untranslated region of PAK1 influences schizophrenia susceptibility.

Authors:  Juan Jiang; Jianxiong Long; Weijun Ling; Guifeng Huang; Li Su
Journal:  Exp Ther Med       Date:  2017-01-12       Impact factor: 2.447

2.  Extracting Disease-Relevant Features with Adversarial Regularization.

Authors:  Junxiang Chen; Li Sun; Ke Yu; Kayhan Batmanghelich
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2021-12

Review 3.  The genetics of early-onset bipolar disorder: A systematic review.

Authors:  Kevin P Kennedy; Kathryn R Cullen; Colin G DeYoung; Bonnie Klimes-Dougan
Journal:  J Affect Disord       Date:  2015-05-15       Impact factor: 4.839

4.  The conserved ASTN2/BRINP1 locus at 9q33.1-33.2 is associated with major psychiatric disorders in a large pedigree from Southern Spain.

Authors:  Cristòfol Vives-Bauzà; Antònia Flaquer; Josep Pol-Fuster; Francesca Cañellas; Laura Ruiz-Guerra; Aina Medina-Dols; Bàrbara Bisbal-Carrió; Bernat Ortega-Vila; Jaume Llinàs; Jessica Hernandez-Rodriguez; Jerònia Lladó; Gabriel Olmos; Konstantin Strauch; Damià Heine-Suñer
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.